FindTrial
Sign In

This study looks at how chemicals called enzymes released from liver might relate to the seriousness of blockages in arteries supplying the heart

A prospective observational study on alanine aminotransferase & aspartate aminotransferase associated with severity of stenosis in coronary artery disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085470
Enrollment
120
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who had diagnosed with coronary artery disease Patients who underwent coronary angiography Patients with age group above 18 years

Exclusion criteria

Exclusion criteria: Patients with the prevailing or prevailed liver injury Patients with noncardiac reasons Patients with aortic valve disease Patients with Cardiomyopathy and Hypertensive emergency

Design outcomes

Secondary

MeasureTime frame
To correlate the AST & ALT and stenosis diameter in Coronary artery disease.Timepoint: Day 1 after diagnosis of coronary artery disease—

Primary

MeasureTime frame
To observe the elevation of aspartate aminotransferase and alanine aminotransferase in Coronary artery disease and evaluate the diameter of stenosis in Coronary artery disease using quantitative coronary angiographyTimepoint: Day 1 after diagnosis of coronary artery disease—

Countries

India

Contacts

Public ContactDr K Karthik

SRM Medical college and hospital

Karthikk1@srmist.edu.in9444586662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026